Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Michael Stabin
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Concepts & Ideas
Devices
Chemicals & Drugs
Procedures
Anatomy
Objects
Occupations
Activities & Behaviors
Sign-in to see full Profile
Network (preview)
9
Siegel, Jeffry
5
Breitz, Hazel
4
Sparks, Richard
4
Cremonesi, Marta
4
Traino, Antonio
3
Wessels, Barry
3
Yoriyaz, Hélio
3
Russell, JR
3
Tosi, Giampiero
3
Eckerman, Keith
3
Paganelli, Giovanni
3
Chinol, Marco
3
Di Martino, Fabio
3
Bolch, Wesley
3
Bouchet, Lionel
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Michael Stabin (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2008: Stabin Michael G
Radiopharmaceuticals for nuclear cardiology: radiation dosimetry, uncertainties, and risk.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(9):1555-63.
-
2008: Vicini Paolo; Brill A Bertrand; Stabin Michael G; Rescigno Aldo
Kinetic modeling in support of radionuclide dose assessment.
Seminars in nuclear medicine 2008;38(5):335-46.
-
2008: Stabin Michael G; Brill A Bertrand
State of the art in nuclear medicine dose assessment.
Seminars in nuclear medicine 2008;38(5):308-20.
-
2008: Stabin Michael G; Brill A Bertrand
Radiation dosimetry and exposure in nuclear medicine.
Seminars in nuclear medicine 2008;38(5):306-7.
-
2008: Cittanti Corrado; Uccelli Licia; Pasquali Micol; Boschi Alessandra; Flammia Claudia; Bagatin Elisa; Casali Massimiliano; Stabin Michael G; Feggi Luciano; Giganti Melchiore; Duatti Adriano
Whole-body biodistribution and radiation dosimetry of the new cardiac tracer 99mTc-N-DBODC.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(8):1299-304.
-
2008: Shi C Y; Xu X George; Stabin Michael G
SAF values for internal photon emitters calculated for the RPI-P pregnant-female models using Monte Carlo methods.
Medical physics 2008;35(7):3215-24.
-
2008: Stabin Michael G
Update: the case for patient-specific dosimetry in radionuclide therapy.
Cancer biotherapy & radiopharmaceuticals 2008;23(3):273-84.
-
2008: Stabin Michael G
Uncertainties in internal dose calculations for radiopharmaceuticals.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(5):853-60.
-
2008: Verberne Hein J; Sokole Ellinor Busemann; van Moerkerken Astrid F; Deeterink Joop H W M; Ensing Geert; Stabin Michael G; Somsen G Aernout; van Eck-Smit Berthe L F
Clinical performance and radiation dosimetry of no-carrier-added vs carrier-added 123I-metaiodobenzylguanidine (MIBG) for the assessment of cardiac sympathetic nerve activity.
European journal of nuclear medicine and molecular imaging 2008;35(4):798-807.
-
2007: Traino A C; Ferrari M; Cremonesi M; Stabin M G
Influence of total-body mass on the scaling of S-factors for patient-specific, blood-based red-marrow dosimetry.
Physics in medicine and biology 2007;52(17):5231-48.
-
2006: Delbeke Dominique; Coleman R Edward; Guiberteau Milton J; Brown Manuel L; Royal Henry D; Siegel Barry A; Townsend David W; Berland Lincoln L; Parker J Anthony; Hubner Karl; Stabin Michael G; Zubal George; Kachelriess Marc; Cronin Valerie; Holbrook Scott
Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(5):885-95.
-
2006: Stabin Michael G; Peterson Todd E; Holburn George E; Emmons Mary A
Voxel-based mouse and rat models for internal dose calculations.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(4):655-9.
-
2005: Siegel Jeffry A; Sparks Richard B; Sharkey Robert M; Wessels Barry W; Bolch Wesley E; Bouchet Lionel G; Breitz Hazel B; Meredith Ruby F; Sgouros George; Stabin Michael G
Blood-based red marrow dosimetry: where's the beef?
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(8):1404-6; author reply 1405-6.
-
2005: Stabin Michael G; Sparks Richard B; Crowe Eric
OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(6):1023-7.
-
2004: Wessels Barry W; Bolch Wesley E; Bouchet Lionel G; Breitz Hazel B; Denardo Gerald L; Meredith Ruby F; Stabin Michael G; Sgouros George;
Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(10):1725-33.
-
2004: Stabin Michael G
Proposed addendum to previously published fetal dose estimate tables for 18F-FDG.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(4):634-5.
-
2003: Stabin Michael G; Siegel Jeffry A
Physical models and dose factors for use in internal dose assessment.
Health physics 2003;85(3):294-310.
-
2003: Stabin Michael G
Radiotherapy with internal emitters: what can dosimetrists offer?
Cancer biotherapy & radiopharmaceuticals 2003;18(4):611-7.
-
2003: Wiseman Gregory A; Leigh Bryan R; Dunn William L; Stabin Michael G; White Christine A
Additional radiation absorbed dose estimates for Zevalin radioimmunotherapy.
Cancer biotherapy & radiopharmaceuticals 2003;18(2):253-8.
-
2003: Wiseman Gregory A; Kornmehl Ellen; Leigh Bryan; Erwin William D; Podoloff Donald A; Spies Stewart; Sparks Richard B; Stabin Michael G; Witzig Thomas; White Christine A
Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(3):465-74.
-
2003: Siegel Jeffry A; Stabin Michael G; Sparks Richard B
Total-body and red marrow dose estimates.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(2):320-1; author reply 321-3.
-
2003: Siegel Jeffry A; Yeldell Dion; Goldenberg David M; Stabin Michael G; Sparks Richard B; Sharkey Robert M; Brenner Arnold; Blumenthal Rosalyn D
Red marrow radiation dose adjustment using plasma FLT3-L cytokine levels: improved correlations between hematologic toxicity and bone marrow dose for radioimmunotherapy patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(1):67-76.
-
2003: Stabin M G
Developments in the internal dosimetry of radiopharmaceuticals.
Radiation protection dosimetry 2003;105(1-4):575-80.
-
2002: Stabin Michael G; Siegel Jeffry A; Sparks Richard B
Sensitivity of model-based calculations of red marrow dosimetry to changes in patient-specific parameters.
Cancer biotherapy & radiopharmaceuticals 2002;17(5):535-43.
-
2002: Stabin Michael G; da Luz Lydia C Q P
Decay data for internal and external dose assessment.
Health physics 2002;83(4):471-5.
-
2002: Stabin M G; Eckerman K F; Bolch W E; Bouchet L G; Patton P W
Evolution and status of bone and marrow dose models.
Cancer biotherapy & radiopharmaceuticals 2002;17(4):427-33.
-
2002: Loureiro E C M; Lima F R A; Stabin M G
A voxel-based head-and-neck phantom built from tomographic colored images.
Cellular and molecular biology (Noisy-le-Grand, France) 2002;48(5):461-4.
-
2002: Siegel Jeffry A; Stabin Michael G; Brill A Bertrand
The importance of patient-specific radiation dose calculations for the administration of radionuclides in therapy.
Cellular and molecular biology (Noisy-le-Grand, France) 2002;48(5):451-9.
-
2002: Kennel S J; Mirzadeh S; Eckelman W C; Waldmann T A; Garmestani K; Yordanov A T; Stabin M G; Brechbiel M W
Vascular-targeted radioimmunotherapy with the alpha-particle emitter 211At.
Radiation research 2002;157(6):633-41.
-
2002: Di Martino F; Traino A C; Brill A B; Stabin M G; Lazzer M
A theoretical model for prescription of the patient-specific therapeutic activity for radioiodine therapy of Graves' disease.
Physics in medicine and biology 2002;47(9):1493-9.
-
2002: Stabin M G; Yoriyaz H
Photon specific absorbed fractions calculated in the trunk of an adult male voxel-based phantom.
Health physics 2002;82(1):21-44.
-
2001: Stabin M G; Brill A B
Monoclonal antibodies in the treatment of hematologic malignancies: radiation dosimetry aspects.
Current pharmaceutical biotechnology 2001;2(4):351-6.
-
2001: Stabin M G
Investigation of patient release criteria.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(6):916.
-
2001: Stabin M G; Howell R W; Colas-Linhart N C
Modeling radiation dose and effects from internal emitters in nuclear medicine: from the whole body to individual cells.
Cellular and molecular biology (Noisy-le-Grand, France) 2001;47(3):535-43.
-
2001: Yoriyaz H; Stabin M G; dos Santos A
Monte Carlo MCNP-4B-based absorbed dose distribution estimates for patient-specific dosimetry.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(4):662-9.
-
2001: Stabin M G; Siegel J A; Sparks R B; Eckerman K F; Breitz H B
Contribution to red marrow absorbed dose from total body activity: a correction to the MIRD method.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(3):492-8.
-
2001: Traino A C; Di Martino F; Lazzeri M; Stabin M G
Study of the correlation between administered activity and radiation committed dose to the thyroid in 131I therapy of Graves' disease.
Radiation protection dosimetry 2001;95(2):117-24.
-
2000: Cremonesi M; Ferrari M; Chinol M; Bartolomei M; Stabin M G; Sacco E; Fiorenza M; Tosi G; Paganelli G
Dosimetry in radionuclide therapies with 90Y-conjugates: the IEO experience.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 2000;44(4):325-32.
-
2000: Yoriyaz H; dos Santos A; Stabin M G; Cabezas R
Absorbed fractions in a voxel-based phantom calculated with the MCNP-4B code.
Medical physics 2000;27(7):1555-62.
-
2000: Stabin M G; Konijnenberg M; Knapp F F; Spencer R H
Monte Carlo modeling of radiation dose distributions in intravascular radiation therapy.
Medical physics 2000;27(5):1086-92.
-
2000: Stabin M G; Breitz H B
Breast milk excretion of radiopharmaceuticals: mechanisms, findings, and radiation dosimetry.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(5):863-73.
-
2000: Eckerman K F; Stabin M G
Electron absorbed fractions and dose conversion factors for marrow and bone by skeletal regions.
Health physics 2000;78(2):199-214.
-
2000: Traino A C; Di Martino F; Lazzeri M; Stabin M G
Influence of thyroid volume reduction on calculated dose in radioiodine therapy of Graves' hyperthyroidism.
Physics in medicine and biology 2000;45(1):121-9.
-
2000: Stabin M G; Konijnenberg M W
Re-evaluation of absorbed fractions for photons and electrons in spheres of various sizes.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(1):149-60.
-
1999: Cremonesi M; Ferrari M; Zoboli S; Chinol M; Stabin M G; Orsi F; Maecke H R; Jermann E; Robertson C; Fiorenza M; Tosi G; Paganelli G
Biokinetics and dosimetry in patients administered with (111)In-DOTA-Tyr(3)-octreotide: implications for internal radiotherapy with (90)Y-DOTATOC.
European journal of nuclear medicine 1999;26(8):877-86.
-
1999: Stabin M G
Internal dosimetry in the use of radiopharmaceuticals in therapy--science at a crossroads?
Cancer biotherapy & radiopharmaceuticals 1999;14(2):81-9.
-
1999: Siegel J A; Thomas S R; Stubbs J B; Stabin M G; Hays M T; Koral K F; Robertson J S; Howell R W; Wessels B W; Fisher D R; Weber D A; Brill A B
MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(2):37S-61S.
-
1999: Cremonesi M; Ferrari M; Chinol M; Stabin M G; Grana C; Prisco G; Robertson C; Tosi G; Paganelli G
Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patients.
European journal of nuclear medicine 1999;26(2):110-20.
-
1998: Stubbs J B; Evans J F; Stabin M G
Radiation absorbed doses to the walls of hollow organs.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1998;39(11):1989-95.
-
1998: Stabin M G; Gelfand M J
Dosimetry of pediatric nuclear medicine procedures.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1998;42(2):93-112.
-
1997: Stabin M G
Health concerns related to radiation exposure of the female nuclear medicine patient.
Environmental health perspectives 1997;105 Suppl 6():1403-9.
-
1997: Stabin M G; Kooij P P; Bakker W H; Inoue T; Endo K; Coveney J; de Jong R; Minegishi A
Radiation dosimetry for indium-111-pentetreotide.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(12):1919-22.
-
1997: Russell J R; Stabin M G; Sparks R B; Watson E
Radiation absorbed dose to the embryo/fetus from radiopharmaceuticals.
Health physics 1997;73(5):756-69.
-
1997: Russell J R; Stabin M G; Sparks R B
Placental transfer of radiopharmaceuticals and dosimetry in pregnancy.
Health physics 1997;73(5):747-55.
-
1997: Stabin M G; Stubbs J B; Russell J R
Review of the fetal radiation doses received from 59Fe kinetic studies at Vanderbilt University in the 1940's.
Health physics 1997;72(5):701-7.
-
1996: Stabin M G
MIRDOSE: personal computer software for internal dose assessment in nuclear medicine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(3):538-46.
-
1996: Breitz H; Mills G; Siegel J; Stabin M; Wessels B W
The 10th International Conference on Monoclonal Antibody Immunoconjugates for Cancer: Radiodosimetry and Radiopharmaceuticals for Therapy.
Cancer biotherapy & radiopharmaceuticals 1996;11(1):25-42.
-
1995: Evans J F; Stabin M G; Stubbs J B
Specific absorbed fractions of energy from internal photon sources in brain tumor and cerebrospinal fluid.
Medical physics 1995;22(3):331-40.
-
1994: Stabin M G; Eckerman K F; Ryman J C; Williams L E
Bremsstrahlung radiation dose in yttrium-90 therapy applications.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1994;35(8):1377-80.
-
1993: Mozley P D; Stubbs J B; Kung H F; Selikson M H; Stabin M G; Alavi A
Biodistribution and dosimetry of iodine-123-IBF: a potent radioligand for imaging the D2 dopamine receptor.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(11):1910-7.
-
1993: Stabin M G
Radiation dose to the upper spine from therapeutic administrations of iodine-131-sodium iodide.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(4):695-6.
-
1993: Watson E E; Stabin M G; Siegel J A
MIRD formulation.
Medical physics 1993;20(2 Pt 2):511-4.
-
1992: Stabin M; Taylor A; Eshima D; Wooter W
Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(1):33-40.
-
1991: Stabin M G; Watson E E; Marcus C S; Salk R D
Radiation dosimetry for the adult female and fetus from iodine-131 administration in hyperthyroidism.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(5):808-13.
-
1991: Washburn L C; Sun T T; Lee Y C; Byrd B L; Holloway E C; Crook J E; Stubbs J B; Stabin M G; Brechbiel M W; Gansow O A
Comparison of five bifunctional chelate techniques for 90Y-labeled monoclonal antibody CO17-1A.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(3):313-21.
-
1991: Stabin M G; Stubbs J B; Watson E E
Dosimetry of swallowed non-absorbed technetium 99m radiopharmaceuticals in paediatric patients.
European journal of nuclear medicine 1991;18(4):288-92.
-
1989: Watson E E; Stabin M G; Davis J L; Eckerman K F
A model of the peritoneal cavity for use in internal dosimetry.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1989;30(12):2002-11.
-
1988: Washburn L C; Lee Y C; Sun T T; Byrd B; Crook J E; Stabin M G; Steplewski Z
Preclinical assessment of 90Y-labeled monoclonal antibody CO17-1A, a potential agent for radioimmunotherapy of colorectal carcinoma.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1988;15(6):707-11.
-
1986: Marcus C; Stabin M G; Watson E E
Pediatric radiation dose from [111In]leukocytes.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1986;27(7):1220-1.
-
1986: Brihaye C; Butler T A; Knapp F F; Guillaume M; Watson E E; Stabin M G
A new osmium-191/iridium-191m radionuclide generator system using activated carbon.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1986;27(3):380-7.
-
1985: Marcus C S; Stabin M G; Watson E E; Kuperus J H
Contribution of contaminant indium-114m/indium-114 to indium-111 oxine blood dosimetry.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1985;26(9):1091-3.
Sign-in to see more
